E
Epizyme Inc
F:EPE
Epizyme Inc
F:EPE
Price:
559
EUR
3.33%
Market Closed
Market Cap:
€92.2B
Balance Sheet
Balance Sheet Decomposition
Epizyme Inc
Epizyme Inc
Balance Sheet Decomposition is not available for
Epizyme Inc
Epizyme Inc
Balance Sheet
Epizyme Inc
Epizyme Inc
Currency: USD
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
98
|
124
|
190
|
208
|
78
|
227
|
87
|
140
|
168
|
98
|
|
| Cash Equivalents |
98
|
124
|
190
|
208
|
78
|
227
|
87
|
140
|
168
|
98
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
164
|
50
|
154
|
242
|
205
|
78
|
|
| Total Receivables |
2
|
34
|
2
|
0
|
0
|
1
|
21
|
4
|
4
|
7
|
|
| Accounts Receivables |
2
|
34
|
2
|
0
|
0
|
0
|
20
|
3
|
3
|
7
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
11
|
3
|
|
| Other Current Assets |
1
|
2
|
3
|
5
|
7
|
9
|
12
|
15
|
18
|
19
|
|
| Total Current Assets |
101
|
160
|
195
|
213
|
249
|
286
|
273
|
399
|
405
|
206
|
|
| PP&E Net |
2
|
2
|
4
|
4
|
3
|
3
|
2
|
23
|
20
|
22
|
|
| PP&E Gross |
2
|
2
|
4
|
4
|
3
|
3
|
2
|
23
|
20
|
22
|
|
| Accumulated Depreciation |
2
|
3
|
3
|
5
|
6
|
7
|
8
|
8
|
7
|
8
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
47
|
43
|
|
| Other Long-Term Assets |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
19
|
|
| Total Assets |
104
N/A
|
163
+57%
|
199
+22%
|
218
+9%
|
252
+16%
|
289
+15%
|
276
-5%
|
425
+54%
|
474
+12%
|
289
-39%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
3
|
5
|
8
|
5
|
5
|
7
|
5
|
9
|
10
|
10
|
|
| Accrued Liabilities |
4
|
7
|
7
|
11
|
16
|
18
|
20
|
26
|
33
|
35
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
28
|
23
|
2
|
2
|
0
|
0
|
13
|
0
|
0
|
0
|
|
| Total Current Liabilities |
36
|
35
|
17
|
18
|
22
|
25
|
38
|
34
|
43
|
45
|
|
| Long-Term Debt |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
36
|
230
|
232
|
|
| Other Liabilities |
43
|
24
|
22
|
29
|
29
|
29
|
5
|
23
|
15
|
32
|
|
| Total Liabilities |
79
N/A
|
59
-25%
|
39
-34%
|
48
+24%
|
51
+5%
|
54
+7%
|
43
-21%
|
94
+120%
|
289
+209%
|
310
+7%
|
|
| Equity | |||||||||||
| Common Stock |
76
|
0
|
0
|
0
|
0
|
0
|
0
|
37
|
36
|
36
|
|
| Retained Earnings |
53
|
56
|
111
|
244
|
354
|
488
|
587
|
757
|
989
|
1 240
|
|
| Additional Paid In Capital |
2
|
160
|
271
|
413
|
556
|
724
|
820
|
1 051
|
1 138
|
1 183
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
25
N/A
|
104
+317%
|
160
+54%
|
170
+6%
|
202
+19%
|
235
+17%
|
233
-1%
|
331
+42%
|
185
-44%
|
21
N/A
|
|
| Total Liabilities & Equity |
104
N/A
|
163
+57%
|
199
+22%
|
218
+9%
|
252
+16%
|
289
+15%
|
276
-5%
|
425
+54%
|
474
+12%
|
289
-39%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
2
|
29
|
34
|
42
|
58
|
69
|
79
|
98
|
102
|
106
|
|
| Preferred Shares Outstanding |
62
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
